Gad Rennert, M.D., Ph.D.

Gad Rennert, M.D., Ph.D.

Chairman, Dept. Community Medicine and Epidemiology,
Carmel Medical Center and Technion Faculty of Medicine,
and Director, CHS National Israeli Cancer Control Center

Phone: 972-4-825-0474
Fax: 972-4-834-4358
E-mail
: rennert@clalit.org.il

Education

INSTITUTION AND LOCATION DEGREE YEARS FIELD OF STUDY
University of the Negev, Beer-Sheba, Israel MD 1978-84 Medicine
School of Public Health, UNC, Chapel Hill PhD 1986-88 Public Health/Epidemiology

A. Current positions and appointments

1990 - Head, Dept. of Epidemiology and Disease Prevention, CHS Headquarters, Tel Aviv,
1992 - Chairman, Department of Community Medicine and Epidemiology, Clalit Health Services, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel.
1992 - Director, Clalit Health Services National Israeli Cancer Control Center
1992 - Director, The National Israeli Breast Cancer Screening Program. Israel Ministry of Health
1992 - Israeli delegate, Europe Against Cancer, Commission of the European Communities, Breast Cancer Screening. (EBCN)
1993- Member, National Israeli Oncology Council, Ministry of Health.
1993- International Breast Cancer Screening Network (IBSN) (NCI coordinated).
1993 - Member, Ministry of Health - Head Scientist Committee on Epidemiology.
1994 - Member, Strategic Planning Committee, National Center for Health Policy.
1994 - Member, Managing Board, Israel Cancer Association.
1999 - Member, Ministry of Health - Head Scientist Committee on Research on Cancer.
1998 - Council member, European Association for Cancer Research.
1998 - Member, Planning Committees of National Colorectal Cancer Detection Program.
2000 - Member, Joint Sub-Committee on Onco-genetics, National Oncology Council and Gynecology, Obstetrics and Genetics Council, Ministry of Health.
2000 - Member, Research Committee, National Women's Health Council, Ministry of Health.
2000 - Member, Committee on Preventive Medicine in the Community. The Israel National Institute for Health Policy and Health Services Research. Chairman and program director for workshop on closing the gap between preventive medicine and clinical medicine.
2001 - Advisor on cancer epidemiology and cancer control, Israel Cancer Association
2001 - Chair, Inter-Ministerial Committee on Carcinogens and Mutagens, Ministries of Health, Environmental Protection, Commerce and Industry, Agriculture and Labor and Welfare.
2003 - Member, CHS Strategic Team on Quality Management, Preventive Medicine and Medical Research.
2003 - Board member, International Society of Cancer Chemoprevention.
2003 - Member, Israel Center for Disease Control committee on exceptional morbidity.
2004 - Member, International Colorectal Cancer Screening Network (ICRCSN) (joint USA-CDC, Cancer Research UK, American Cancer Society coordination).
2005 - Director, National Israeli Colon Cancer Program. Israeli Ministry of Health
2007 - Member, European Society for Medical Oncology (ESMO) Faculty list, Cancer Prevention

B. Publications

  • Rennert G., Saltz-Rennert H., Wanderman K., Weitzman S. Size of acute myocardial infarcts in patients with Diabetes Mellitus. Am J Cardiol 1985;55:1629-1630.
  • Strogatz DS., Siscovick DS., Weiss NS., Rennert G. Wife's Level of Education and Husband's Risk of Primary Cardiac Arrest. Am J Public Health 1988;78:1491-1493.
  • Rennert G., Tamir A., Epstein L. Lung Cancer in Israel, 1962-1982. I. Jews and Arabs. Eur J Epidemiol 1988;4:461-469.
  • Spencer T., Rennert G., Schade E., Shalom J. Early Detection of Breast Cancer: Compromise Guidelines for a Primary Care Setting. J Cancer Educ 1989;4:121-123.
  • Siscovick DS., Strogatz DS., Weiss NS., Rennert G. Early Retirement and Risk of Primary Cardiac Arrest. Am J Publ Health 1990;80:207-208.
  • Rennert G., Rennert HS., Katz L., Epstein L. Lung Cancer in Israel, 1962-1982. II. Ethnic Differences Among Jews. Eur J Epidemiol 1990:6;142-149.
  • Rennert G., Epstein L. Urban-Rural Differences in Lung Cancer Occurrence. Time Trends in Jews in Israel. Lung Cancer 1990;5:9-14.
  • Rennert G. The Value of Mammography in Different Ethnic Groups in Israel - Cost Effectiveness Analysis Using CAN*TROL. Cancer Detect Prev 1991;15:477-482.
  • Rennert G., Rennert HS., Epstein L. Is There a Time Trend in the Smoking-Lung Cancer Histology Relationship? Cancer Detect Prev 1991;15:99-101.
  • Rennert G. Teaching Preventive Oncology to Primary Care Physicians - Pretest Assessment of Knowledge in Northern Israel. Family Practice 1991;8:19-22.
  • Rennert G., Rennert HS., Epstein L. Lung Cancer Histology in Jews and Arabs, Israel 1962-1982. Am Rev Resp Dis 1991;143:721-726.
  • Ostbye T., Bojan F., Rennert G., Hurlen P., Garner B. Establishing an International Computer Network for Research and Teaching in Public Health and Epidemiology. Eur J Epidemiol 1991;7:34-38.
  • Rennert G., Rennert HS., Epstein L. Lung Cancer Histology in Major Ethnic Groups Among the Jews. Israel, 1962-1982. Eur J Epidemiol 1991;7:68-76. Stein M., Lachter J., Rennert G., Bartal A., Kuten A. Thyroid Cancer and Multiple Primary Malignancies in Israel (1960-1976). J Surg Oncol 1991;47:221-224
  • Robinson E., Neugut AI., Murray T., Rennert G. A Comparison of the Clinical Characteristics of First and Second Primary Head and Neck Cancers: A Population-Based Study. Cancer 1991;68:189-192.
  • Rennert G. Considerations and Parameters in Planning a National Cancer Control Program - The Implications of the Case of Israel. Publ Health Rev 1991;18:117-128.
  • Rennert G. Premature Mortality, Israel, 1986. Isr J Med Sci 1992;28:81-85.
  • Robinson E., Nasrallah S., Adler Z., Rennert G., Neugut AI. The Clinical, Demographic and Follow-up Characteristics of Patients with Two Primary Metachronous Tumors (one of the Tumors in the Colon). Dis Colon Rectum 1992;35:457-461.
  • Robinson E., Bar-Daroma R., Rennert G., Neugut AI. A Comparison of the Clinical Characteristics of Second Primary and Single Primary Sarcoma - A Population Based Study. J Surg Oncol 1992;50:263-266.
  • Stein M., Loberant N., Laviov M., Rennert G., Lachter J., Kuten A. Second Cancer in Patients Treated for Testicular Seminoma. J Surg Oncol 1992;49:16-19.
  • Robinson E., Rennert G., Rennert HS., Neugut AI. Survival of First and Second Primary Breast Cancer. Cancer 1993;71:172-176.
  • Bornstein J., Ben David Y., Pascal B., Zakai R., Rennert G., Hornstein L., Abramovici H. Occult Human Papillomavirus Cervical Infection: Reverse DNA Hybridization Detection and Review of the Literature. Isr J Obstet Gynecol 1993;2:58-65.
  • Bornstein J., Ben-David Y., Horenstein L., Rennert G., Pascal B., Faktor J., Werhow M., Bekerman A., Zakai R., Abramovici H. Human Papillomavirus DNA in Jewish Israeli Women. The CERVIX and the lower female genital tract 1993;1:147-152.
  • Roguin A., Weyl Ben-Arush M., Rennert G., Rosenthal J. Malignant Solid Tumors in the First Year of Life. Harefuah 1994;126:574-576.
  • Rennert G. Implications of the Russian Immigration on Mortality Patterns in Israel. Int. J. Epidemiol 1994;23:751-756.
  • Robinson E., Adler Z., Nasrallah S., Rennert G., Neugut AI. Clinical characteristics of second primary tumors following breast cancer. Isr J Med Sci 1995;31:169-171.
  • Robinson E., Bar-Deroma R., Epelbaum R., Rennert G., Neugut AI. The clinical characterisitcs of maligant Non-Hodgkin's Lymphoma as a second primary tumor: A population-based survey. Lymphoma & Leukemia 1995;20:297-301.
  • Rennert G., Robinson E., Rennert HS., Neugut AI. Clinical characteristics of metachronous colorectal tumors. Int J Cancer 1995; 60: 743-747.
  • Robinson E., Adler Z., Nasrallah S., Kuten A., Steiner M., Rennert G., Neugut AI. Clinical characteristics of patients with a second primary tumor in the endometrium or ovary. Eur. J. Gynaec. Oncol. 1995;3:195-198,
  • Ge X., Yannai S., Rennert G., Gruener N., Fares FA. 3, 3' -diindolylmethane induces apoptosis in human cancer cells. Biochemical and Biophysical Reserach Communications 1996;228:153-158.
  • Ore L., Hagoel L., Shifroni G., Rennert G. Compliance with Mammography screening in Israeli women: The impact of a pre-scheduled invitation and of letter type. Isr J. Med Sci 1997;33:103-111.
  • Weinberg HS., Nevo E., Korol A., Fahima T., Shapiro S., Rennert G. Molecular changes in the offspring of liquidators from the Chernobyl disaster area in Israel. Environmental Health Perspectives 1997; 105(supp 6): 1479-1481.
  • Prokocimer M., Unger R., Rennert HS., Rotter V., Rennert G. Pooled-analysis of p53 Mutations in Hematological Malignancies Human Mutation 1998; 12:4-18.
  • Fares A.F., Ge X., Yannai S., Rennert G. Dietary Indole Derivatives Induce Apoptosis in Human Breast Cancer Cells. Adv Exp Med Biol 1998; 451:153-157.
  • Hagoel L., Ore L., Neter E., Shifroni G., Rennert G. The Gradient in Mammography Screening Behavior – a Lifestyle Marker. Social Science & Medicine, 1999; 48:1281-1290.
  • Weinberg HSH Cytotoxic Phenotype, Korol A, Nevo E, Shapiro S, Rennert G. Increased mutation rate in offspring of the Chernobyl accident liquidators. Int J Radiation Med 1999;2:67-70.
  • Yakirevich E., Ben Itzhak O., Rennert G., Kovacs ZG., Resnick MB. of Tumor Infiltrating Lymphocytes in Medullary Carcinoma of the Breast. Modern Pathology 1999; 12:1050-1056.
  • Ballard-Barbash R., Klabunde C., Paci E., Broeders M., Coleman EA., Fracheboud J., Bouchard F., Rennert G., Shapiro S. Breast Cancer Screening in 22 countries: Delivery of services, notification of results, and outcomes ascertainment. Eur J Cancer Prevention 1999;8:417-426.
  • Rennert G., Rennert HS., Pitlik S., Finkelstein R., Kitzes-Cohen R. Epidemiology of Candidemia - A Nationwide Survey in Israel. Infection, 2000; 28: 26-29.
  • Lev Z., Kislitsin D., Rennert G., Lerner A. Utilization of K-ras Mutations Identified in Stool DNA for the Early Detection of Colorectal Cancer. J Cell Biochem 2000; Suppl 34: 35-39.
  • Yakirevich E, Maroun L, Cohen O, Ben Izhak O, Rennert G., Resnick MB Apoptosis, proliferation, and Fas(APO-I, CD95)/Fas ligand expression in medullary carcinoma of the breast. J Pathol 2000;192:166-173.
  • Hagoel L., Dishon S., Almog R., Silman Z., Rennert G. Proband family adherence to familial-genetic counseling. Psycho-Oncology 2000; 9:522-527.
  • Dunning AM., Durocher F., Healey CS., McBridel SE., Carlomango F., Xu CF., Dawson E., Teare DM., Rhodes S., Uedal S., Lai E., Luben RN., Van Rensberg L., Mannermaa A., Kataja V., Rennert G., Dunham I., Bentley D., Purvis I., Easton D., Ponder BAJ. The extent of linkage disequilibrium in four populations with distinct demographic histories. Am J Human Genetics 2000;67:1544-54
  • Rozen G.S., Rennert G., Rennert HS., Diab G., Daud D., Ish Shalom S. Calcium Intake and Bone Mass Development Among Israeli Adolescent Girls. J Am Coll Nutr 2001;20:219-224
  • Rennert G., Peterburg Y. Prevalence of Chronic Diseases in Israel. Israel Med Assoc J - IMAJ 2001;3:404-8.
  • Weinberg H.S., Korol A B., Kirzhner V.M., Nevo E., Shapiro S., Rennert G., Piatak O., Stepanova E.I., Skvarskaja E., Very High Mutation Rate in Offspring of the Chernobyl Accident Liquidators. Proc R Soc Lon B 2001;268:1001-1005
  • Ore L., Hagoel L., Lavi I., Rennert G. Screening with Fecal Occult Blood Test (FOBT) for Colorectal Cancer: Assessment of Two Modes Attempting to Achieve Adherence. Eur J Cancer Prevention 2001;10:251-6
  • Giordano TJ., Shedden KA., Schwartz DR., Kuick R., Taylor JMG., Lee N., Misek DE., Greenson JK., Kardia SLR., Beer DG., Rennert G., Cho KR., Gruber SB, Fearon ER, Hanash S. Organ-Specific Molecular Classification of Primary Lung, Colon and Ovarian Adenocarcinomas Using Gene Expression Profiles. Am J Pathol 2001;159:1231-1238.
  • Rennert G., Rennert HS., Miron E., Peterburg Y. Population colorectal cancer screening with fecal occult blood test Cancer Epidemiology, Biomarkers and Prevention 2001;10:1165-1168
  • Hagoel L., Ore L., Neter E., Silman Z., Rennert G. Clustering Women's Health Behaviors. Health Education & Behavior 2002; 29:170-182.
  • Rennert G., Luz N., Tamir A., Peterburg Y. Chronic Disease Prevalence in Immigrants to Israel from the former USSR. J Immig Health 2002;4:29-33
  • Kislitsin D., Lerner A., Rennert G., Lev Z. K-ras mutations in sporadic colorectal tumors in Israel: Unusual high frequency of codon 13 mutations and an evidence for a non-homogenous representation of mutation subtypes Digest Dis Sci 2002;47:1073-9
  • Davidson S., Leshanski L., Rennert G., Eidelman S., Amikam D. Maternal mosaicism for a second mutational event - a novel deletion - in a familial adenomatous polyposis family harboring a new germ-line mutation in the alternatively spliced-exon 9 region of APC. Human mutation 2002;19:83-4.
  • Narod SA, Dub MP ,Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencherb D, Heimdahl K, Moller P, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen S, Robson M, Ainsworth P, Olsson H, Gareth Evans, Osborne M, Couch F, Foulkes W, Warner E, Kim-Sing C, Olopade O, Tung N, Saal H, Weitzel J, Merajver S, Stoppa-Lyonnet D, Jernstrom H, Sun P, Brunet JS. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 carriers. J Natl Cancer Inst 2002;94:1773-9.
  • Rennert H., Bercovich D., Hubert A., Abeliovich D., Bar Shira A., Soloviov S., Rozovsky U., Shreiber L., Matzkin H., Rennert G., Kadouri L., Peretz T., Yaron Y., Orr-Urtreger A. A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet 2002;71:981-4
  • Gruber SB., Ellis NA, ,Rennert G. (Corresponding Author), Offit K. BLM heterozygosity and the risk of colorectal cancer. Science 2002; 297: 2013
  • Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Shia J, Markowitz A, Figer A, Friedman E, Hamel N, Farber D, Greenwood CM, Walsh T, Marcus V, Tomsho L, Gebert J, Bressac-de Paillerets B, Weitzel J, Gordon PH, MacNamara E, King MC, Hampel H, de la Chapelle A, Boyd J, Offit K, Rennert G, Chong G, Ellis NA. The founder mutation MSH2*1906G>C is an important cause of Hereditary Non Polyposis Colorectal Cancer in the Ashkenazi Jewish population. Am J Hum Genetics Dec 2002 ;71:1395-1412.
  • Teare MD, Dunning AM, Durocher F, Rennert G, Easton DF Sampling distribution of summary linkage disequilibrium measures. Ann Hum Genet. 2002 May;66(Pt 3):223-33. Rennert G. Political Interpretation of Scientific Evidence – Case study of breast cancer screening policies around the world. Recent Results in Cancer Research. Tumor Prevention and Genetics. 2003;163: 140-150.
  • Greenson JK, Bonner JD, Ben-Yzhak O, Cohen HI, Miselevich I, Resnick MB, Trougouboff P, Tomsho LD, Kim E, Low M, Rennert G, Gruber SB. Phenotype of Microsatellite Unstable Colorectal Carcinomas: Well- differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 2003; 27:563-70
  • Rozen GS., Dodiuk RP., Rennert G., Rennert HS., Diab G., Ish-Shalom S. Calcium supplementation provides a larger window of opportunities for bone mass accretion after menarche. Am J Clin Nutr. 2003;78:993-8
  • Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, Greene MH, Maslansky B, Fischbein A, Gruber SB, Rennert G, Ronchetti RD, Hewitt SM, Struewing JP, Iscovich J. A Two-Fold Increase in BRCA Mutation-Related Prostate Cancer Among Ashkenazi Israelis is Not Associated with Distinctive Histopathology. J Med Genet 2003;40:787-792.
  • Shedden KA., Taylor JMG., Giordano TJ., Kuick R., Misek DE., Rennert G., Schwartz DR., Gruber SB., Logsdon C., Simeone D., Kardia SLR., Greenson JK., Cho KR., Beer DG., Fearon ER., Hanash S. Accurate Molecular Classification of Human Cancers Based on Gene Expression Using a Simple Classifier With a Pathologic Tree-Based Framework. Am J Pathol. 2003;163:1985-95
  • Niell BL, Long JC, Rennert G, Gruber SB. Genetic anthropology of the colorectal cancer susceptibility allele APC I1307K. Am J Human Genetics 2003; 73:1250-1260.
  • Hagoel L, Neter E, Dishon S, Barnett O, Rennert G. BRCA1/2 Mutation carriers: living with susceptibility. Community Genetics 2003;6:242-8
  • Niell BL., Rennert G., Bonner JD., Tomsho L., Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst 2004;96:15-21
  • Atzmon G, Schechter C, Greiner W, Davidson D, Rennert G, Barzilai N. Clinical Phenotype of Families with Longevity. J Am Geriatr Soc 2004:52;274-277
  • Lipkin SM, Rozek LS, Rennert G, Yang W, Chen PC, Hacia J, Hunt N, Shin B, Fodor S, Kokoris M, Greenson JK, Fearon E, Lynch H, Collins F, Gruber SB. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nature Genetics 2004 Jul;36(7):694-9
  • Lavie O, Horenriech G, Ben-Arie A, Rennert G, Cohen Y, Keider R, Sagi S, Levy Lahad E, Auslander R, Beller U. BRCA Germline Mutations in Women with Uterine Serous Papillary Carcinoma. Gynecologic Oncology 2004;92:521-4
  • Bar-Joseph N., Reisfeld D., Tirosh E., Stoler Z., Rennert G. Neuro-behavioral cognitive performances of children exposed to low dose radiation in the Chernobyl accident. Am J Epidemiol 2004;160:453-9
  • Yankaskas BC, Klabunde CN, Ancelle-Park R, Rennert G, Wang H, Fracheboud J, Pou G, Bulliard JL for the International Breast Cancer Screening Network. International comparison of recall rates for screening mammography. Can it be done? J Med Screen 2004;11:187-193
  • Rennert G., Dishon S., Rennert HS, Fares F. Phenotypic characteristics of families with BRCA1 and BRCA2 mutations in Israel. Eur J Cancer Prevention 2005; 14:357-61
  • Poynter JN, Gruber SB, Higgins PDR, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G. Statins and the Risk of Colorectal Cancer. New England Journal of Medicine 2005;352:2184-92.
  • Shin B., Chen H, Rozek LS, Paxton L, Peel DJ, Anton-Culver H, Rennert G, Mutch DG, Goodfellow PJ, Gruber SB, Lipkin SM. Low Allele Frequency of MLH1 D132H in American Colorectal and Endometrial Cancer Patients. Dis Colon Rectum 2005;48(9):1723-7
  • Rozek L.S., Lipkin SM, Fearon ER, Hanash S., Giordano TJ., Kuick R., Misek DE., Taylor JMG., Rennert G., Gruber S.B. CDX2 Polymorphisms, RNA Expression, and Risk of colorectal cancer. Cancer Research 2005;65:5488-92
  • Dodiuk-Gad RP, Rozen GS, Rennert G, Rennert HS, Ish-Shalom S. Sustained effect of short-term calcium supplementation on bone mass in adolescent girls with low calcium intake. Am J Clin Nutr. 2005;81:168-74.
  • Rennert G., Dishon S., Tomsho LP., Almog R., Low M., Bonner JD., Rennert HS., Gruber SB. Prevalence of adenomas in carriers of the I1307k APC polymorphism. Diseases Colon Rectum 2005;48:2317-21
  • Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA. The Effect of Pregnancy as a Risk Factor for Breast Cancer in BRCA1/BRCA2 Mutation Carriers. Int J Cancer 2005;117(6):988-91
  • Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Isaacs C, Kim-Sing C, Ainsworth P, Couch F, Garber JE, Daly M, Rosen B, Olopade O, Karlan B, Tung N, Saal HM, Weitzel J, Eng C, Sun P, Narod SA. Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study. J Clin Oncol. 2005 Oct 20;23(30):7491-6.
  • Poynter JN, Cooney KA, Bonner JD, Tomsho LP, Rennert G, Gruber SB. APC I1307K and the Risk of Prostate Cancer. Cancer Epidemiol Biomarker Prevent 2006;15:468-73
  • Rennert G. Breast Cancer in: Freedman LS, Edwards BK, Ries LAG, Young JL, eds. Cancer Incidence in Four Member Countries of the MECC Compared with US SEER. National Cancer Institute MECC Monograph, 2006:73-81.
  • Orr-Urtreger A, Bar Shira A, Bercovich D, Matarasso N, Rozovsky U, Rosner S, Soloviov S, Rennert G, Hubert A, Rennert H, Matzkin H. RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Cancer Epidemiol Biomarker Prevent 2006;15:474-9
  • Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C,Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SA and the Hereditary Breast Cancer Clinical Study Group. Spontaneous and Therapeutic Abortions and the Risk of Breast Cancer Among BRCA Mutation Carriers. Breast Cancer Res. 2006;8(2):R15. Epub 2006 Mar 21
  • Rozek L.S., Rennert G., Gruber S.B. E1317Q is not associated with colorectal cancer in a population-based case- control study of northern Israelis. Cancer Epidemiology, Biomarkers and Prevention 2006;15:2325-7
  • Kotsopoulos J, Lubinski J,. Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Olopade OI, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA and the Hereditary Breast Cancer Clinical Study Group. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2007 Oct;105(2):221-228. Lavie O, Barnett O, Narod S, Rennert G. The risk of developing uterine sarcoma after tamoxifen use. Int J Gynecol Cancer 2008;18:352-6.
  • Rennert G., Brenner DE, Rennert HS, Lev Z. K-ras in stool from test cards improves the positive predictive value of FOBT. Cancer Letters 2007;253:258-264
  • Bar-Joseph N, Rennert G, Tamir A, Ore L, Bar-Joseph G. Ethnic differences in the epidemiologic characteristics of severe trauma due to falls from height among children in Northern Israel. Israel J Med Sci 2007;9:603-606
  • Chaiter Y, Rennert G, Fischler R, Rennert H.S, Rosen G, Gruber S.B, Ben Amotz A. Dietary Intake of Carotenoid Isomers in Israel. Int J Vitamin Nutrition Research 2007 Nov;77(6):398-405
  • Gruber SB, Moreno V, Rozek LS, Ballinger D , Rennert HS, Bonner JD, Almog R, Low M, Greenson JK, Giordano TJ, Lejbkowicz F, Douglas JA, Levin AM, Fearon ER, Boehnke M, Rennert G. Genetic Variation in 8q24 Associated with Risk of Colorectal Cancer. Cancer Biology and Therapeutics 2007 Jul 2;6(7) 1143-7
  • Pujana MA, Han JDJ, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, Assmann V, ElShamy WM, Rual JF, Levine D, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, Solé X, Hernández P, Lázaro C, Nathanson KL, Weber BL, Cusick ME, Hill DE, Offit K, Livingston DM, Gruber SB, Parvin JD, Vidal M. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature Genetics 2007 Nov;39(11):1338-1349. Epub 2007 Oct 7. Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, GEMO, Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Górski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H, EMBRACE, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H, Spurdle AB, Chen X, Waddell N, Cloonan N, kConFab, Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Irene L. Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MPG, Greene MH, Prindiville SA, Osorio A, Benítez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlina H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF and Chenevix-Trench G on behalf of the Consortium of Investigators of Modifiers of BRCA1/2. RAD51 135G>C modifies breast cancer risk among BRCA2 mutation carriers: Results from a combined analysis of 19 studies. Am J Human Genetics 2007 Dec;81(6):1186-200. Epub 2007 Oct 16.
  • Rennert G., Bisland-Naggan S., Bar-Joseph N., Zhang S., Barnett-Griness O., Rennert HS., Narod S. Outcome of Breast Cancer in BRCA Mutation Carriers in Israel. New England Journal of Medicine 2007;357:115-23
  • Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat. 2008; 29(6):852-60.
  • Lavie O, Gruber SB, Leibkowicz F, Dishon S, Rennert G. Gynecological malignancies in Ashkenazi families with the MSH2 A636P founder mutation. Am J Obstet Gynecol 2008 Aug;199(2):148.e1-3
  • Almog R, Hagoel L, Tamir A, Barnett O, Rennert G. Quality Control in a National Program for the Early Detection of Breast Cancer Women's Satisfaction With the Mammography Process. Women's Health Issues 2008;18:110-7.
  • Antoniou AC Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kämpjärvi K, Nevanlinna H, Simard J, Beesley J, Chen X; the Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI, Blum JL, Couch FJ, Peterlongo P, Manoukian S, Barile M, Radice P, Szabo CI, Pereira LH, Greene MH, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H; OCGN, Gerdes AM, Caligo MA, Laitman Y, Kaufman B, Milgrom R, Friedman E; The Swedish BRCA1 and BRCA2 study collaborators, Domchek SM, Nathanson KL, Osorio A, Llort G, Milne RL, Benítez J, Hamann U, Hogervorst FB, Manders P, Ligtenberg MJ, van den Ouweland AM; The DNA-HEBON collaborators, Peock S, Cook M, Platte R, Evans DG, Eeles R, Pichert G, Chu C, Eccles D, Davidson R, Douglas F; EMBRACE, Godwin AK, Barjhoux L, Mazoyer S, Sobol H, Bourdon V, Eisinger F, Chompret A, Capoulade C, Bressac-de Paillerets B, Lenoir GM, Gauthier-Villars M, Houdayer C, Stoppa-Lyonnet D; GEMO, Chenevix-Trench G, Easton DF; on behalf of CIMBA.on behalf of CIMBA. Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Human Genet 2008 ;82(4):937-48.
  • Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, Semple C, Clark AJ, Reid FJ, Smith LA, Kavoussanakis K, Koessler T, Pharoah PD, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Schmidt CO, Hampe J, Chang-Claude J, Hoffmeister M, Brenner H, Wilkening S, Canzian F, Capella G, Moreno V, Deary IJ, Starr JM, Tomlinson IP, Kemp Z, Carvajal-Carmona L, Webb E, Broderick P, Vijayakrishnan J, Houlston RS, Rennert G, Ballinger D, Rozek L, Gruber SB, Matsuda K, Kidokoro T, Nakamura Y, Zanke BW, Greenwood CM, Rangrej J, Kustra R, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature Genetics 2008 ;40(5):631-7
  • Raskin L, Pinchev M, Arad C, Lejbkowicz F, Tamir A, Rennert HS, Rennert G, Gruber SB. FGFR2 Is a Breast Cancer Susceptibility Gene in Jewish and Arab Israeli Populations. Cancer Epidemiol Biomarkers Prev 2008;17 1060-1065.
  • Yizhaki D., Rennert H.S., Rosen G., Rennert G. Validity and Reproducibility of a Semi-quantitative Food Frequency Questionnaire adapted to an Israeli Population. The Open Nutrition Journal 2008;2:9-14.
  • Samiran S, Gruber SB, Mukherjee B, Rennert G. Inference of Haplotype Effect in Matched Case-Control Study Using unphased Genotype Data. International Journal of Biostatistics 2008 ;4(1):6 Greenson JK, Huang SC , Herron C, Bonner JD, Tomsho LD, Kim E, Ben Yizhak O, Cohen HI, Trougouboff P, Bejhar J, Sova Y, Pinchev M, Rennert G, Gruber SB. Pathologic Predictors of Microsatellite Instability in Colorectal Cancer. Am J Surg Pathol 2008 Sep 30. [Epub ahead of print] 2009;33:126-133. Mukherjee B, Ahn J, Gruber SB, Rennert G, Moreno V, Chatterjee N. Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs. Genet Epidemiol. 2008 Nov;32(7):615-26.
  • Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The Public Prefers Fecal Occult Blood Test (FOBT) over Colonoscopy for Colorectal Cancer (CRC) Screening. Eur J Cancer Prevention 2008 Oct;17(5):430-7
  • Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA; the Hereditary Breast Cancer Clinical Study Group. Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers. J Natl Cancer Inst. 2008 Oct 1;100(19):1361-7. Epub 2008 Sep 23.
  • Khoury Shakour S., Leijbcovich F, Raskin L, Barnett-Griness O., Rennert H, Gruber S, Rennert G. Recreational physical activity modifies the association between the common GH1 Polymorphism and colorectal cancer risk. Cancer Epidemiol Biomarker Prev 2008 Dec;17(12):3314-8.
  • Toland AE, Rozek LS, Presswala S, Rennert G, Gruber SB. PTPRJ Haplotypes and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2782-5.
  • Neter, E., Almog, R., Ore, L., Rennert, G., Hagoel, L. The Israeli National Program for Early Detection of Breast Cancer: Women as the Target Population. Cognition, Brain, Behavior 2009;13:195-205.
  • Raskin L., Rennert G., Gruber SB. FOXP3 germline polymorphisms are not associated with risk of breast cancer. Cancer Genetics Cytogenetics 2009;190:40-2.
  • Taddei TH, Kacena KA, Yang M, Yang R, Malhotra A , Sadan S, Boxer M, Aleck KA, Rennert G, Mistry PK. The under-recognized progressive nature of N370S Gaucher Disease and assessment of cancer risk in 403 patients. Am J Hematol 2009 Apr;84(4):208-14. Epub 2009 Jan 12.
  • Raskin L, Lejbkowicz F, Barnett-Griness O, Dishon S, Almog R, Rennert G. BRCA1 Breast Cancer Risk Is Modified by CYP19 Polymorphisms in Ashkenazi Jews. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1617-23. Epub 2009 Apr 14.
  • Vilar E, Mukherjee B, Kuick R, Raskin L, Misek DE, Taylor JM, Giordano TJ, Hanash SM, Fearon ER, Rennert G, Gruber SB. Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway. Clin Cancer Res. 2009 Apr 15;15(8):2829-39. Epub 2009 Apr 7.
  • Khoury-Shakour S, Lejbkowicz F, Barnett-Griness O, Tamir A, Pinchev M, Rennert G. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations. Eur J Cancer Prev. 2009 Sep;18(5):361-7
  • Chaiter Y, Gruber SB, Ben-Amotz A, Almog R, Rennert HS, Fischler R, Rozen G, Rennert G. Smoking attenuates the negative association between carotenoids consumption and colorectal cancer risk. Cancer Causes Control. 2009 Oct ; 20(8):1327-1338.
  • Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X; The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G; OCGN, Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE; HEBON, Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F; GEMO, Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Staudigl C, Hansen TV, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deißler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF; Georgia Chenevix-Trench; on behalf of CIMBA. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet. 2009 Nov 15;18(22):4442-56. Epub 2009 Aug 5.
  • Rennert G, Rennert HS, Pinchev M, Lavi O, Gruber SB. The use of HRT and the risk of colorectal cancer. J Clin Oncol 2009 Sep 20;27(27):4542-7. Epub 2009 Aug 24.
  • Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X; kConFab8, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL; OCGN11, Domchek SM, Nathanson KL, Manoukian S, Radice P, Konstantopoulou I, Blanco I, Laborde AL, Durán M, Osorio A, Benitez J, Hamann U, Hogervorst FB, van Os TA, Gille HJ; HEBON23, Peock S, Cook M, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Brewer C; EMBRACE3, Hughes DJ, Coupier I, Giraud S, Coulet F, Colas C, Soubrier F, Rouleau E, Bièche I, Lidereau R, Demange L, Nogues C, Lynch HT; GEMO1242, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Sutter C, Deissler H, Schaefer D, Froster UG; GC-HBOC4344454647484950, Aittomäki K, Nevanlinna H, McGuffog L, Easton DF, Chenevix-Trench G, Stoppa-Lyonnet D. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2009 Oct 20;101(8):1456-60. Epub 2009 Aug 25.
  • Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, García EG, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deißler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer. 2009 Dec 15;101(12):2048-54. Epub 2009 Nov 17.
  • Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ullrich A, Travado L, Santini LA, Grassi L, De Lorenzo F, Costa A, Dangou JM, Bisanti L, Seniori Costantini A, Abu-Rmeileh N, Kamal M, Federico M, Saracci R, Rennert G, Stefanini A, Cavalli F, Cazap E, Redmond K, O'Reilly S, Muti P, Casali P, Gatta G, Ferrari A, Koifman S, Bah E, Pastore G, Barr R, Lombardo C, Frazzingaro C, Ciampichini R, Baili P; ICCC-3 Session B Group. International collaborations in cancer control and the Third International Cancer Control Congress. Tumori. 2009 Sep-Oct;95(5):579-96.
  • Kershenbaum A, Lavi I, Rennert G, Almog R. Faecal occult blood screen test performance indicators in warfarin treated patients. Dis Colon Rectum 2010 Feb;53(2):224-9.
  • Rennert G, Rennert HS, Pinchev M, Gruber SB. A Case-Control Study of Levothyroxine and the Risk of Colorectal Cancer. J Natl Cancer Inst. 2010 Apr 21;102(8):568-72. Epub 2010 Mar 19.
  • Rozek LS, Herron CM, Greenson JK, Moreno V, Capella G, Rennert G, Gruber SB. Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):838-43. Epub 2010 Mar 3.
  • Gornick MC, Castellsague X, Sanchez G, Giordano TJ, Vinco M, Greenson JK, Capella G, Raskin L, Rennert G, Gruber SB, Moreno V. Human Papillomavirus is Not Associated with Colorectal Cancer in a Large International Study. Cancer Causes and Control 2010 May; 21(5):737-43. Epub 2010 Jan 20.
  • Lipkin SM, Chao L, Moreno V, Rozek LS, Rennert H, Pinchev M, Dizon D, Rennert G, Kopelovich L, Gruber SB. Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase modifies the Chemopreventive Activity of Statins for Colorectal Cancer. Cancer Prev Res (Phila Pa) 2010 May;3(5):597-603. Epub 2010 Apr 19.
  • Rennert G, Pinchev M, Rennert HS. Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer. J Clin Oncol 2010 Aug 1;28(22):3577-81. Epub 2010 Jun 21.
  • Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, Mitchell G, Lindeman GJ, Stapleton A, Suthers G, Evans DG, Cruger D, Blanco I, Mercer C, Kirk J, Maehle L, Hodgson S, Walker L, Izatt L, Douglas F, Tucker K, Dorkins H, Clowes V, Male A, Donaldson A, Brewer C, Doherty R, Bulman B, Osther PJ, Salinas M, Eccles D, Axcrona K, Jobson I, Newcombe B, Cybulski C, Rubinstein WS, Buys S Townshend S, Friedman E, Domchek S, Ramon y Cajal T, Spigelman A, Teo SH, Nicolai N, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Eyfjord J, Falconer A, Grönberg H, Hamdy F, Johannsson O, Khoo V, Kote-Jarai Z, Lilja H, Lubinski J, Melia J, Moynihan C, Peock S, Rennert G, Schröder F, Sibley P, Suri M, Wilson P, Bignon YJ, Strom S, Tischkowitz M, Liljegren A, Ilencikova D,Abele A, Kyriacou K; van Asperen C, Kiemeney L, The IMPACT Study Collaborators, Easton DF, Eeles RA. Targeted Prostate Cancer Screening in Men with Mutations in BRCA1 and BRCA2 Detects Aggressive Prostate Cancer: Preliminary analysis of the results of the Impact Study. British Journal of Urology International 2011 Jan;107(1):28-39.
  • Truong T, Hung RJ, Amos CI, Wu X, Bickeböller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, Wrensch M, Hansen H, Kelsey KT, Matsuo K, Tajima K, Schwartz AG, Wenzlaff A, Seow A, Ying C, Staratschek-Jox A, Nürnberg P, Stoelben E, Wolf J, Lazarus P, Muscat JE, Gallagher CJ, Zienolddiny S, Haugen A, van der Heijden HF, Kiemeney LA, Isla D, Mayordomo JI, Rafnar T, Stefansson K, Zhang ZF, Chang SC, Kim JH, Hong YC, Duell EJ, Andrew AS, Lejbkowicz F, Rennert G, Müller H, Brenner H, Le Marchand L, Benhamou S, Bouchardy C, Teare MD, Xue X, McLaughlin J, Liu G, McKay JD, Brennan P, Spitz MR. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 7;102(13):959-71. Epub 2010 Jun 14.
  • Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D; EMBRACE, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L, Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S, Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P; GEMO Study Collaborators, Hogervorst FB, Rookus MA, Jager A, van den Ouweland A, Hoogerbrugge N, van der Luijt RB, Meijers-Heijboer H, Gómez García EB; HEBON, Devilee P, Vreeswijk MP, Lubinski J, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Górski B, Cybulski C, Spurdle AB, Holland H; kConFab, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Preisler-Adams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL, Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R, Andrulis IL, Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci C; SWE-BRCA, Loman N, Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen M, Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A, Radice P, Caldes T, de la Hoya M, Singer CF, Fink-Retter A, Greene MH, Mai PL, Loud JT, Guidugli L, Lindor NM, Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus SJ, Gayther SA, Phelan C, Narod S, Szabo CI; MOD SQUAD, Benitez J, Osorio A, Nevanlinna H, Heikkinen T, Caligo MA, Beattie MS, Hamann U, Godwin AK, Montagna M, Casella C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J, Olopade O, Simard J, Soucy P, Rubinstein WS, Arason A, Rennert G, Martin NG, Montgomery GW, Chang-Claude J, Flesch-Janys D, Brauch H; GENICA, Severi G, Baglietto L, Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D, Fountzilas G, Fasching PA, Beckmann MW, Dos Santos Silva I, Peto J, Lambrechts D, Paridaens R, Rüdiger T, Försti A, Winqvist R, Pylkäs K, Diasio RB, Lee AM, Eckel-Passow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah PP, Offit K, Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet. 2010 Oct;42(10):885-92. Epub 2010 Sep 19. Lavie O, Narod S, Lejbkowicz F, Dishon S, Goldberg Y, Gemer O, Rennert G. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Ann Oncol. Epub 2011 Apr;22(4):964-6.
  • Samadder NJ, Mukherjee B, Huang SC, Ahn J, Rennert HS, Greenson JK, Rennert G, Gruber SB. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer 2011 Apr 15;117(8):1640-8.
  • Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'olio V, Peterlongo P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH, Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL; for the Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Sunde L, Cruger D, Birk Jensen U, Caligo M, Friedman E, Kaufman B, Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernström H, Lindblom A, Rantala J, Stenmark-Askmalm M, Melin B; for SWE-BRCA, Nathanson K, Domchek S, Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Durán M, Tejada MI, Godino J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, Luijt RB, Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst F, Rookus M; for HEBON, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ, Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S; for EMBRACE, Godwin AK, Stoppa-Lyonnet D, Pauw AD, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Faivre L; for GEMO, Loustalot C, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M, Vénat-Bouvet L; for GEMO, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; for the Breast Cancer Family Registry, Singer CF, Dressler AC, Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jønson L, Agnarsson BA, Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov E, Tihomirova L, Blanco I, Lazaro C, Ramus SJ, Sucheston L, Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel C, Meindl A, Lochmann M, Arnold N, Heidemann S, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Kast K, Schönbuchner I, Caldes T, Hoya MD, Aittomäki K, Nevanlinna H, Simard J, Spurdle AB, Holland H, Chen X; for kConFab, Platte R, Chenevix-Trench G, Easton DF; on behalf of CIMBA. Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction. Cancer Res. 2010 Dec 1;70(23):9742-54.
  • Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Gauthier-Villars M, Sobol H, Longy M, Frenay M, Gemo Study Collaborators, Hogervorst FB, Rookus MA, Collée JM, Hoogerbrugge N, van Roozendaal KE; HEBON Study Collaborators, Piedmonte M, Rubinstein W, Nerenstone S, Van Le L, Blank SV, Caldés T, de la Hoya M, Nevanlinna H, Aittomäki K, Lazaro C, Blanco I, Arason A, Johannsson OT, Barkardottir RB, Devilee P, Olopade OI, Neuhausen SL, Wang X, Fredericksen ZS, Peterlongo P, Manoukian S, Barile M, Viel A, Radice P, Phelan CM, Narod S, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H; OCGN, Toland AE, Montagna M, D'Andrea E, Friedman E, Laitman Y, Borg A, Beattie M, Ramus SJ, Domchek SM, Nathanson KL, Rebbeck T, Spurdle AB, Chen X, Holland H; kConFab, John EM, Hopper JL, Buys SS, Daly MB, Southey MC, Terry MB, Tung N, Overeem Hansen TV, Nielsen FC, Greene MI, Mai PL, Osorio A, Durán M, Andres R, Benítez J, Weitzel JN, Garber J, Hamann U, Peock S, Cook M, Oliver C, Frost D, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Walker L, Eason J, Barwell J, Godwin AK, Schmutzler RK, Wappenschmidt B, Engert S, Arnold N, Gadzicki D, Dean M, Gold B, Klein RJ, Couch FJ, Chenevix-Trench G, Easton DF, Daly MJ, Antoniou AC, Altshuler DM, Offit K. Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer. PLoS Genet. 2010 Nov 17;6(11). doi: 10.1371/annotation/b28cf02d-7196-4a16-8b36-6562a0b84f75.
  • Raskin L, Schwenter F, Freytsis M, Tischkowitz M, Wong N, Chong G, Narod S, Levine D, Bogomolniy F, Aronson M, Thibodeau S, Hunt K, Rennert G, Gallinger S, Gruber S, Foulkes W. Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome. Clin Genet. 2011 Jun;79(6):512-522.
  • Shulman K, Cohen I, Barnett-Griness O, Gruber SB, Lejbkowicz F, Rennert G. Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients. Cancer. 2011 Jul 15;117(14):3156-62. doi: 10.1002/cncr.25735. Epub 2011 Feb 1.
  • Rennert G, Pinchev M, Rennert HS, Gruber SB. Use of Bisphosphonates and Reduced Risk of Colorectal Cancer. J Clin Oncol. 2011 Mar 20;29(9):1146-50.
  • Vilar E., Bartnik C., Stenzel S., Moreno V., Donate MI, Morgan M., Raskin L, Rennert G., Mukherjee B., Gruber SB. MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite instable colorectal cancers. Cancer Research 2011 Apr 1;71(7):2632-42.
  • Kershenbaum A, Kershenbaum A, Tarabeia J, Stein N, Lavi I, Rennert G. Unraveling seasonality in population averages: An examination of seasonal variation in glucose levels in diabetes patients using a large population-based dataset. Chronobiol Int 2011 May;28(4):352-60.
  • Mukherjee B, Rennert G (as first), Ahn J, Dishon S, Lejbkowicz F, Rennert HS, Shiovitz S, Moreno V, Gruber SB. High Risk of Colorectal and Endometrial Cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterology 2011 Jun;140(7):1919-26. Epub 2011 Mar 16.
  • Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Mai PL, Greene MH, Piedmonte M, Rubinstein WS; HEBON, Hogervorst FB, Rookus MA, Collée JM, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer HE, Van Roozendaal CE, Caldes T, Perez-Segura P, Jakubowska A, Lubinski J, Huzarski T, Blecharz P, Nevanlinna H, Aittomäki K, Lazaro C, Blanco I, Barkardottir RB, Montagna M, D'Andrea E; kConFab, Devilee P, Olopade OI, Neuhausen SL, Peissel B, Bonanni B, Peterlongo P, Singer CF, Rennert G, Lejbkowicz F, Andrulis IL, Glendon G, Ozcelik H; Ontario Cancer Genetics Network, Toland AE, Caligo MA; SWE-BRCA, Beattie MS, Chan S; UKFOCR, Domchek SM, Nathanson KL, Rebbeck TR, Phelan C, Narod S, John EM, Hopper JL, Buys SS, Daly MB, Southey MC, Terry MB, Tung N, Hansen TV, Osorio A, Benitez J, Durán M, Weitzel JN, Garber J, Hamann U; EMBRACE, Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Eeles R, Izatt L, Paterson J, Brewer C, Hodgson S, Morrison PJ, Porteous M, Walker L, Rogers MT, Side LE, Godwin AK, Schmutzler RK, Wappenschmidt B, Laitman Y, Meindl A, Deissler H, Varon-Mateeva R, Preisler-Adams S, Kast K, Venat-Bouvet L, Stoppa-Lyonnet D, Chenevix-Trench G, Easton DF, Klein RJ, Daly MJ, Friedman E, Dean M, Clark AG, Altshuler DM, Antoniou AC, Couch FJ, Offit K, Gold B. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet. 2011 Nov;130(5):685-99. Epub: May 20.
  • Valle L, Capellá G, Moreno VR, Rennert G, Gruber SB. Reply: Allelic imbalance of TGFBR1 is not a major contributor to the genetic predisposition to colorectal cancer. Br J Cancer. 2011 Apr 26;104(9):1519-20.
  • Gornick MC, Moreno V, Rennert G, Gruber SB. Adiponectin Gene and Risk of Colorectal Cancer Br J Cancer 2011 Aug 9;105(4):562-4.
  • Saliba W, Barnett O, Rennert HS, Lavi I, Rennert G. Vitamin D status in Israeli subjects before the initiation and after cessation of vitamin D supplements. Calcified Tissue International 2011 Nov;89(5):419-25.
  • Maxwell CA, Benítez J, Gómez-Baldó L, Osorio A, Bonifaci N, Fernández-Ramires R, Costes SV, Guinó E, Chen H, Evans GJ, Mohan P, Català I, Petit A, Aguilar H, Villanueva A, Aytes A, Serra-Musach J, Rennert G, Lejbkowicz F, Peterlongo P, Manoukian S, Peissel B, Ripamonti CB, Bonanni B, Viel A, Allavena A, Bernard L, Radice P, Friedman E, Kaufman B, Laitman Y, Dubrovsky M, Milgrom R, Jakubowska A, Cybulski C, Gorski B, Jaworska K, Durda K, Sukiennicki G, Lubiński J, Shugart YY, Domchek SM, Letrero R, Weber BL, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE; HEBON; EMBRACE, Easton DF, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, Nevanlinna H, Heikkinen T, Couch FJ, Lindor NM, Wang X, Godwin AK, Caligo MA, Lombardi G, Loman N, Karlsson P, Ehrencrona H, von Wachenfeldt A; SWE-BRCA, Bjork Barkardottir R, Hamann U, Rashid MU, Lasa A, Caldés T, Andrés R, Schmitt M, Assmann V, Stevens K, Offit K, Curado J, Tilgner H, Guigó R, Aiza G, Brunet J, Castellsagué J, Martrat G, Urruticoechea A, Blanco I, Tihomirova L, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB; BCFR, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Deissler H, Varon-Mateeva R, Sutter C, Niederacher D, Imyamitov E, Sinilnikova OM, Stoppa-Lyonne D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Fert Ferrer S, Collonge-Rame MA, Mortemousque I; GEMO Study Collaborators, Spurdle AB, Beesley J, Chen X, Healey S; kConFab, Barcellos-Hoff MH, Vidal M, Gruber SB, Lázaro C, Capellá G, McGuffog L, Nathanson KL, Antoniou AC, Chenevix-Trench G, Fleisch MC, Moreno V, Pujana MA. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. PLoS Biol. 2011 Nov;9(11):e1001199. Epub 2011 Nov 15.
  • Rennert G, Lejbkowicz F, Cohen I, Pinchev M, Rennert HS, Barnett-Griness O. MutYH mutation carriers have increased breast cancer risk. Cancer. 2011 Sep 22. doi: 10.1002/cncr.26506. [Epub ahead of print]
  • Saliba W, Barnett O, Rennert HS, Lavi I, Rennert G. The relationship between serum 25(OH)D and parathyroid hormone levels Am J Med 2011 Dec;124(12):1165-70.
  • Gronich N, Lavi I, Rennert G. Higher risk of venous thrombosis associated with drospirenone- combined-oral-contraceptive CMAJ 2011 Dec 13;183(18):E1319-25
  • Sanz-Pamplona R, Cordero D, Berenguer A, Lejbkowicz F , Rennert HS, Salazar R, Biondo S, Sanjuan X, Pujana MA, Rozek L, Giordano TJ, Ben-Izhak O, Cohen HI, Trougouboff P, Bejhar J, Sova Y, Rennert G, Gruber SB, Moreno V. Gene Expression Differences Between Colon and Rectum Tumors Clinical Cancer Research 2011 Dec 1;17(23):7303-7312.
  • McCormack V, Hung R, Brenner DR, Bickeböller H, Rosenberger A, Muscat JE, Lazarus P, Tjønneland A, Friis S, David C Christiani, Chun E, Le Marchand L, Rennert G, Rennert HS, Andrew AS, Orlow I, Park B, Boffetta P, Duell EJ. Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes and Control 2011 Dec;22(12):1709-20. Epub 2011 Oct 11.
  • Saliba W, Lavi I, Rennert HS, Rennert G. Vitamin D Status in Primary Hyperparathyroidism Eur J Int Med 2012 Jan;23(1):88-92
  • Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, Gruber SB, Rennert G, Moreno V, Ulrich CM, Woods MO, Green RC, Parfrey PS, Prentice RL, Kooperberg C, Jackson RD, Lacroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock SJ, Schoen RE, Chang-Claude J, Hoffmeister M,Brenner H, Frank B, Bézieau S, Küry S, Slattery ML, Hopper JL, Jenkins MA, Le Marchand L, Lindor NM, Newcomb PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD, Casey G. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet. 2012 Feb;131(2):217-34.
  • Saliba W, Rennert HS, Kershenbaum A, Rennert G. Serum 25(OH)D Concentrations in Sunny Israel. Osteoporosis International 2012 Feb;23(2):687-94.
  • Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, Kopelovich L, Lipkin SM, Gruber SB, Moreno V. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis. 2012 Mar;27(2):169-76.
  • Lejbkowicz F, Cohen I, Barnett-Griness O, Pinchev M, Poynter J, Gruber SB, Rennert G. MUTYH mutation carriers in multiethnic populations. Familial Cancer 2012 Feb 28. Epub
  • B. Clinical Research

  • Luria M., Rennert G. Goldenberg S., Rivlin J., Greenberg E., Katz I. Ciliary Ultrastructure in Primary Ciliary Dyskinesia and Other Chronic Respiratory Conditions: The Relevance of Microtubular Abnormalities. Ultrastructural Pathology 1992;16:547-553.
  • Robinson E., Rennert G., Bar-Daroma R., Dori DL., Neugut AI. The Pattern of Diagnosis of a Second Primary Tumor in the Breast. Breast Cancer Research and Treatment 1993;25:211-215.
  • Reshef R., Shiller M., Kinberg R., Rennert H., Rennert G., Herskovits M., Loberant N. A Prospective Study Evaluating the Usefulness of Continuous Supplemental Oxygen in Various Endoscopic Procedures. Isr J Med Sci 1996;32:736-740.
  • Reshef R., Libner E., Rennert HS., Cohen I., Shiler M., Shkolnik T., Rennert G. A community hospital experience with Colonoscopic Polypectomies. Isr J Med Sci 1997;33:666-673.
  • Fisher M, Reger B, Kaplan B, Rennert G. Hormonal replacement therapy, summer 2002, much ado - about what? Harefuah 2002;141:888-890
  • Kogan A., Shapira R., Silman-Stoler Z., Rennert G. Evaluation of chest pain in the ED: Factors affecting triage decisions. Am J Emerg Med 2003;21:68-70
  • Naschitz JE., Kovaleva J., Shaviv N., Rennert G., Yeshurun D. Vascular disorders preceding diagnosis of cancer. Distinguishing the Causal relationship based on Bradford-Hill guidelines. Angiology 2003; 54:11-7
  • Julian-Reynier C, Welkenhuysen M, Hagoel L, Decruyenaere M, Hopwood P, on behalf of the CRISCOM* Working Group. Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services. Eur J Human Genetics 2003;11:725-736.
  • Hopwood P, van Asperen C, Legius E, Eisinger F, Sobol H, Schelberger B, Rennert G, Evans GDR, Evers-Kieboom G, Decruyenaere M, Welkenhuysen M, Nippert I, Hoegal L , Borreani G, Gangeri L, Tibben A, Julian-Reynier C. Cancer Genetics Service Provision: A Comparison of 7 European Centres. Community Genetics 2003;6:192-205
  • Lavie O, Ben-Arie A, Pilip A, Rennert G, Cohen Y, Feiner B, Auslander R. BRCA2 germline mutation in a woman with uterine serous papillary Carcinoma - Case report. Gynecol Oncol. 2005;99(2):486-8 Kogan A., Shapira R., Tamir A., Rennert G. Antithrombotic therapy for prevention of stroke in clinical practice in the ED. Am J Emerg Med 2007;25:1-5
  • Kogan A, Shapira R, Lewis BS, Tamir A, Rennert G. The use of exercise stress testing for the management of low-risk patients with chest pain. Am J Emerg Med 2009 Sep;27(7):889-92.
  • c. Reviews

  • Slater PE., Lubin E., Rennert G. Screening for thyroid abnormalities among immigrants to Israel from the former USSR. Public Health Reviews 1997; 25:43-47.
  • Rennert G. Dietary intervention studies and cancer prevention. European J of Cancer Prevention 2002;11:419-425.
  • Rennert G. Fecal Occult Blood (FOB) Screening – Trial evidence, Practice and Beyond. Recent Results in Cancer Research. Tumor Prevention and Genetics. 2003;163:248-253.
  • Rennert G. Diet and Cancer. Where are we? Where are we going? Proceedings of the Nutrition Society 2003;62:59-62.
  • Winawer S, Faivre J, Selby J, Bertaro L, Chen TH, Kroborg O, Levin B, Mandel J, O'Morain C, Richards M, Rennert G, Russo A, Saito H, Semigfnovsky B, Wong B, Smith R. Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway. Ann Oncol. 2005;16:31-3.
  • Rennert G. Prevention and early detection of colorectal cancer – new horizons. Recent Results in Cancer Research - Cancer Prevention 2007;174(15):179-187
  • d. Editorials

  • Brenner D., Rennert G., Guest editors. Translational Chemoprevention: Breast and colon cancer. Foreword. J Cell Biochem 2000; Suppl 34: v-viii.
  • Brenner DE, Rennert G. Fecal DNA biomarkers for the detection of colorectal neoplasia: Attractive, but is it feasible?. J Natl Cancer Inst 2005;97:1107-1109
  • Rennert G. Are we taking the right approach in planning chemoprevention studies? Nature -Clinical Practice Oncology 2006;3(9):464-5
  • Rennert G. Cancer Prevention: from public health interventions to individual tailoring. Eur J Cancer Prevention 2007;16(3):165-6
  • Rennert G. Are we getting closer to molecular population screening for colorectal cancer? J Natl Cancer Inst. 2009 Jul 1;101(13):902-3. Epub 2009 Jun 17.
  • Rennert G. Colorectal cancer screening: will global warming affect the accuracy of FIT testing? Gut. 2010 Nov;59(11):1451-2.
  • Rennert G. Bisphosphonates: Beyond Prevention of Bone Metastases. J Natl Cancer Inst 2011 Dec 7;103(23):1728-9.
  • e. Group Manuscripts

  • Shapiro S et al, International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Breast cancer screening programs in 22 countries: current policies, administration and guidelines. Int J Epidemiol. 1998 Oct;27(5):735-42.
  • Klabunde C et al, and the International Breast Cancer Screening Network (IBSN) Quality assurance for screening mammography: an international comparison. J Epidemiol Community Health. 2001;55:204-12.
  • Klabunde CN et al, International Breast Cancer Screening Network (IBSN). Quality assurance for screening mammography data collection systems in 22 countries. Int J Technol Assess Health Care. 2001;17:528-41.
  • Hendrick RE et al. International Breast Cancer Screening Network (IBSN). Technical quality control practices in mammography screening programs in 22 countries. Int J Qual Health Care 2002;14:219-26.
  • Klabunde CN et al, and the International Breast Cancer Screening Network. Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries. Int J Qual Health Care. 2002;14:449-61
  • Klabunde C., Bouchard F., Taplin S., Scharpantgen A., Ballard-Barbash R., for the International Breast Cancer Screening Network (IBSN). Quality assurance for screening mammography: an international comparison. J Epidemiol Community Health 2001;55:204-12
  • Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Rosen B, Kim-Sing C, Isaacs C, Domchek S, Sun P; Hereditary Breast Cancer Clinical Study Group. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol. 2006;7(5):402-6.
  • McLaughlin J et al, and the Hereditary Ovarian Cancer Clinical Study Group. Reproductive Risk Factors for Ovarian Cancer in Carriers of BRCA1 or BRCA2 Mutations: a case-control study. Lancet Oncol. 2007;8(1):26-34.
  • Beiner M., Finch A., Rosen B., Lubinski J., Moller P., Ghadirian P., Lynch HT, Friedman E., Sun P., Narod SA et al, and the Hereditary Breast Cancer Clinical Study Group. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. Gynecol Oncol 2007;104(1):7-10.
  • Chenevix-Trench, G., Milne, R.L., Antoniou, A.C., Couch, F., Goldgar, D. on behalf of CIMBA. An international initiative to identify genetic modifiers of BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Research 2007 ;9(2):104.
  • Mitra AV, Bancroft EK, Eeles RA, on behalf of the IMPACT Steering Committee and Collaborators. A review of targeted screening for prostate cancer: introducing the IMPACT Study. Br J Urol Int 2007 Jun;99(6):1350-5.
  • Mitra A, Bancroft E, Eeles R; on behalf of the IMPACT collaborators and steering committee. Targeted Screening in Men with a Genetic Predisposition to Prostate Cancer. The IMPACT Study. Clin Oncol (R Coll Radiol) 2007 Apr;19(3):S39-40.
  • Benson VS, Patnick J, Davies AK, Nadal MR, Smith RA, Atkin WS on behalf of the International Colorectal Cancer Screening Network. Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Cancer 2008 Mar 15;122(6):1357-67
  • Kotsopoulos J, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth P, Cummings S, Sun P, Narod SA and the Hereditary Breast Cancer Clinical Study Group. Infertility, Treatment of Infertility and the Risk of Breast Cancer Among Women With BRCA1 and BRCA2 Mutations. Cancer Causes Control 2008;19:1111-9.
  • Vicus D, Rosen B, Lubinski J, Domchek S, Kauff ND, Lynch HT, Isaacs C, Tung N, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers. Gynecol Oncol. 2009 Oct;115(1):135-7. Epub 2009 Jul 3.
  • Vicus D, Finch A, Rosen B, Fan I, Bradley L, Cass I, Sun P, Karlan B, McLaughlin J, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. Gynecol Oncol. 2010 Aug 1;118(2):155-9. Epub 2010 May 10.
  • Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R; International Cancer Screening Network (ICSN). Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen. 2010;17(3):139-46.

/Print /Close Window